EP1165773A4 - Advanced antigen presentation platform - Google Patents

Advanced antigen presentation platform

Info

Publication number: EP1165773A4
Authority: EP; European Patent Office
Prior art keywords: antigen presentation; presentation platform; advanced; advanced antigen; platform
Prior art date: 1999-02-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00908430A

Other languages

German (de)

French (fr)

Other versions

EP1165773A1 (en

Inventor

Timothy P Coleman

Darrell L Peterson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BioCache Pharmaceuticals Inc

Original Assignee

BioCache Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-02

Filing date

2000-02-02

Publication date

2005-01-05

2000-02-02 Application filed by BioCache Pharmaceuticals Inc filed Critical BioCache Pharmaceuticals Inc

2002-01-02 Publication of EP1165773A1 publication Critical patent/EP1165773A1/en

2005-01-05 Publication of EP1165773A4 publication Critical patent/EP1165773A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Mycology (AREA)
Biotechnology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP00908430A 1999-02-02 2000-02-02 Advanced antigen presentation platform Withdrawn EP1165773A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11852699P	1999-02-02	1999-02-02
US118526P		1999-02-02
PCT/US2000/002413 WO2000046365A1 (en)	1999-02-02	2000-02-02	Advanced antigen presentation platform

Publications (2)

Publication Number	Publication Date
EP1165773A1 EP1165773A1 (en)	2002-01-02
EP1165773A4 true EP1165773A4 (en)	2005-01-05

Family

ID=22379155

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00908430A Withdrawn EP1165773A4 (en)	1999-02-02	2000-02-02	Advanced antigen presentation platform

Country Status (4)

Country	Link
EP (1)	EP1165773A4 (en)
JP (1)	JP2003520568A (en)
AU (1)	AU2977500A (en)
WO (1)	WO2000046365A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US6406705B1 (en)	1997-03-10	2002-06-18	University Of Iowa Research Foundation	Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
DE69932717T2 (en)	1998-05-22	2007-08-09	Ottawa Health Research Institute, Ottawa	METHODS AND PRODUCTS FOR INDUCING MUCOSAL IMMUNITY
KR100863630B1 (en) *	1999-09-25	2008-10-15	유니버시티 오브 아이오와 리써치 파운데이션	Immunostimulatory nucleic acids
ES2335979T3 (en) *	2001-09-14	2010-04-07	Cytos Biotechnology Ag	IMMUNOSTIMULATOR CPG PACKAGING IN VIRUS SIMILAR PARTICLES: PREPARATION METHOD AND ITS USE.
EP1578954A4 (en)	2002-12-11	2010-08-11	Coley Pharm Group Inc	5' cpg nucleic acids and methods of use
US7144712B2 (en)	2003-07-30	2006-12-05	Vaccine Research Institute Of San Diego	Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
WO2005011571A2 (en) *	2003-07-30	2005-02-10	Vaccine Research Institute Of San Diego	Hepatitis virus core proteins as vaccine platforms and methods of use thereof
US7320795B2 (en)	2003-07-30	2008-01-22	Vaccine Research Institute Of San Diego	Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
EP1973608A1 (en)	2005-12-14	2008-10-01	Cytos Biotechnology AG	Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
JP5437797B2 (en)	2006-06-12	2014-03-12	サイトスバイオテクノロジーアーゲー	Method for packaging oligonucleotides into virus-like particles of RNA bacteriophage
AU2007333147B2 (en)	2006-12-12	2013-12-19	Kuros Us Llc	Oligonucleotides containing high concentrations of guanine monomers
CN111593138A (en) *	2019-09-20	2020-08-28	山东省农业科学院家禽研究所	A method for detection of duck hepatitis B virus recombinant polymerase isothermal amplification

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07252300A (en) *	1994-03-11	1995-10-03	Immuno Japan:Kk	Antigen fused protein from duck hepatitis virus and human hepatitis virus and its production
WO1999040934A1 (en) *	1998-02-12	1999-08-19	Immune Complex, Corporation	Strategically modified hepatitis b core proteins and their derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2189254C2 (en) *	1995-06-06	2002-09-20	Америкэн Хоум Продактс Корпорэйшн	Vaccines against hepatitis viruses

2000
- 2000-02-02 EP EP00908430A patent/EP1165773A4/en not_active Withdrawn
- 2000-02-02 AU AU29775/00A patent/AU2977500A/en not_active Abandoned
- 2000-02-02 JP JP2000597425A patent/JP2003520568A/en not_active Withdrawn
- 2000-02-02 WO PCT/US2000/002413 patent/WO2000046365A1/en not_active Ceased

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07252300A (en) *	1994-03-11	1995-10-03	Immuno Japan:Kk	Antigen fused protein from duck hepatitis virus and human hepatitis virus and its production
WO1999040934A1 (en) *	1998-02-12	1999-08-19	Immune Complex, Corporation	Strategically modified hepatitis b core proteins and their derivatives

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHANG C ET AL: "Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to be cis preferential", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 68, no. 8, August 1994 (1994-08-01), pages 5225 - 5231, XP002130379, ISSN: 0022-538X *
HORWICH A L ET AL: "SYNTHESIS OF HEPADNAVIRUS PARTICLES THAT CONTAIN REPLICATION-DEFECTIVE DUCK HEPATITIS B VIRUS GENOMES IN CULTURED HUH7 CELLS", JOURNAL OF VIROLOGY, NEW YORK, US, US, vol. 64, no. 2, 1 February 1990 (1990-02-01), pages 642 - 650, XP000283078, ISSN: 0022-538X *
KENNEY JOHN M ET AL: "Evolutionary conservation in the hepatitis B virus core structure: Comparison of human and duck cores", STRUCTURE (LONDON), vol. 3, no. 10, 1995, pages 1009 - 1019, XP004587927, ISSN: 0969-2126 *
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 02 29 February 1996 (1996-02-29) *
SCHOEDEL F ET AL: "HEPATITIS B VIRUS CORE AND E ANTIGEN: IMMUNE RECOGNITION AND USE ASA VACCINE CARRIER MOIETY", INTERVIROLOGY, XX, XX, vol. 39, no. 1/2, 1996, pages 104 - 110, XP000891467, ISSN: 0300-5526 *
See also references of WO0046365A1 *

Also Published As

Publication number	Publication date
WO2000046365A1 (en)	2000-08-10
EP1165773A1 (en)	2002-01-02
JP2003520568A (en)	2003-07-08
AU2977500A (en)	2000-08-25

Publication	Publication Date	Title
HUP0202885A3 (en)	2004-07-28	Vaccines
GB9911569D0 (en)	1999-07-21	Antibodies
EP1165773A4 (en)	2005-01-05	Advanced antigen presentation platform
GB9901254D0 (en)	1999-03-10	Vaccines
GB9905817D0 (en)	1999-05-05	Methods
GB9929937D0 (en)	2000-02-09	Antigen delivery
GB9930591D0 (en)	2000-02-16	Component for vaccine
GB9825184D0 (en)	1999-01-13	Antigen
GB9915419D0 (en)	1999-09-01	Antigens
GB9904312D0 (en)	1999-04-21	Platform
GB2354793B (en)	2004-03-10	Access platform
AU7788600A (en)	2001-04-30	Colon-tumour-associated antigens
GB0009296D0 (en)	2000-05-31	Movable platform
GB9911692D0 (en)	1999-07-21	Antigenic combinations
GB9930585D0 (en)	2000-02-16	Component for vaccine
GB9929923D0 (en)	2000-02-09	Antigen preparations
PL109287U1 (en)	2000-08-28	Platform
GB2355858B (en)	2001-10-17	Ioniser platform
GB9914943D0 (en)	1999-08-25	Methods
GB9908525D0 (en)	1999-06-09	Methods
AUPQ477299A0 (en)	2000-02-03	Relocatable platform
GB9928197D0 (en)	2000-01-26	85kDA antigen
GB9918051D0 (en)	1999-10-06	Antibodies
GB0212763D0 (en)	2002-07-10	Antibodies
GB9927698D0 (en)	2000-01-19	Therapeutic antibody

Legal Events

Date	Code	Title	Description
2001-05-18	PUAJ	Public notification under rule 129 epc	Free format text: ORIGINAL CODE: 0009425
2001-11-16	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2002-01-02	17P	Request for examination filed	Effective date: 20010823
2002-01-02	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2002-01-02	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2002-03-06	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: BIOCACHE PHARMACEUTICALS, INC.
2005-01-05	A4	Supplementary search report drawn up and despatched	Effective date: 20041123
2005-07-27	17Q	First examination report despatched	Effective date: 20050609
2007-03-28	17Q	First examination report despatched	Effective date: 20050609
2007-10-30	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2007-11-14	RIC1	Information provided on ipc code assigned before grant	Ipc: C12N 15/11 20060101AFI20071008BHEP Ipc: C07K 14/02 20060101ALN20071008BHEP Ipc: A61K 39/385 20060101ALN20071008BHEP Ipc: C07K 14/00 20060101ALI20071008BHEP Ipc: C12N 7/04 20060101ALN20071008BHEP Ipc: A61K 39/39 20060101ALN20071008BHEP
2007-11-14	RTI1	Title (correction)	Free format text: ADVANCED ANTIGEN PRESENTATION PLATFORM AND ADJUVANT
2008-08-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-09-03	18D	Application deemed to be withdrawn	Effective date: 20080313